NCT04236414
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT04236414
Title Investigating Safety, Tolerability, Efficacy and PK of Olaparib in Paediatric Patients With Solid Tumours
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors AstraZeneca
Indications
Therapies
Age Groups: child
Covered Countries GBR | FRA | ESP | DNK | DEU

Facility Status City State Zip Country Details
Research Site København Ø 2100 Denmark Details
Research Site Lille 59000 France Details
Research Site Toulouse 31300 France Details
Research Site Villejuif 94805 France Details
Research Site Heidelberg 69120 Germany Details
Research Site Seoul 03080 South Korea Details
Research Site Seoul 05505 South Korea Details
Research Site Madrid 28009 Spain Details
Research Site Glasgow G51 4TF United Kingdom Details
Research Site Sutton SM2 5PT United Kingdom Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field